RXO (NYSE:RXO) PT Raised to $31.00

RXO (NYSE:RXOGet Free Report) had its target price upped by research analysts at UBS Group from $22.00 to $31.00 in a report issued on Thursday, Benzinga reports. The brokerage presently has a “neutral” rating on the stock. UBS Group’s price target points to a potential upside of 7.94% from the stock’s previous close.

Other equities analysts have also recently issued research reports about the company. TD Cowen lifted their price objective on RXO from $19.00 to $20.00 and gave the company a “hold” rating in a research note on Friday, May 3rd. Barclays lifted their price objective on RXO from $24.00 to $30.00 and gave the company an “overweight” rating in a research note on Tuesday, July 16th. Benchmark restated a “hold” rating on shares of RXO in a research note on Wednesday, June 12th. JPMorgan Chase & Co. boosted their target price on RXO from $16.00 to $25.00 and gave the stock an “underweight” rating in a research note on Tuesday, July 9th. Finally, Raymond James initiated coverage on RXO in a research note on Wednesday, May 15th. They set a “market perform” rating for the company. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $24.45.

Get Our Latest Stock Report on RXO

RXO Trading Down 0.5 %

NYSE RXO traded down $0.13 during trading on Thursday, hitting $28.72. The stock had a trading volume of 864,384 shares, compared to its average volume of 832,853. The company has a market capitalization of $3.38 billion, a PE ratio of -319.11, a PEG ratio of 5.60 and a beta of 1.38. The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 0.60. The firm has a 50 day moving average price of $26.03 and a 200 day moving average price of $22.61. RXO has a twelve month low of $16.94 and a twelve month high of $32.82.

RXO (NYSE:RXOGet Free Report) last released its earnings results on Wednesday, August 7th. The company reported $0.03 earnings per share for the quarter, meeting the consensus estimate of $0.03. The company had revenue of $930.00 million during the quarter, compared to the consensus estimate of $934.14 million. RXO had a positive return on equity of 3.23% and a negative net margin of 0.29%. RXO’s revenue was down 3.4% compared to the same quarter last year. During the same period in the previous year, the company posted $0.08 EPS. As a group, equities research analysts forecast that RXO will post 0.17 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of RXO. Swedbank AB acquired a new position in shares of RXO in the first quarter valued at approximately $76,982,000. MFN Partners Management LP grew its holdings in RXO by 19.8% during the first quarter. MFN Partners Management LP now owns 15,588,555 shares of the company’s stock worth $340,922,000 after acquiring an additional 2,580,330 shares during the period. Vaughan Nelson Investment Management L.P. grew its holdings in RXO by 1,459.0% during the second quarter. Vaughan Nelson Investment Management L.P. now owns 1,628,080 shares of the company’s stock worth $42,574,000 after acquiring an additional 1,523,650 shares during the period. Motley Fool Asset Management LLC grew its holdings in RXO by 287.9% during the first quarter. Motley Fool Asset Management LLC now owns 1,582,324 shares of the company’s stock worth $34,605,000 after acquiring an additional 1,174,361 shares during the period. Finally, Norges Bank acquired a new position in RXO during the fourth quarter worth $24,250,000. Institutional investors and hedge funds own 92.73% of the company’s stock.

RXO Company Profile

(Get Free Report)

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.

Recommended Stories

Analyst Recommendations for RXO (NYSE:RXO)

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.